Ils Foundation - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U85100DL2015NPL278960 Incorporated 13 April 2015 ROC Delhi HQ New Delhi, Delhi, India
Active Private Not For Profit Company pharma
Revenue · FY 2025
₹26.15 Lakh
▲ 56% YoY
Net profit · FY 2025
₹16.01 Lakh
Net margin 61.2%
EBITDA · FY 2025
₹16.01 Lakh
EBITDA margin 61.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
11 yrs
Est. 2015
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Ils Foundation

Data last updated:

Ils Foundation is a private not for profit company based in New Delhi, Delhi, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 13 April 2015 and has been in existence for over 11 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85100DL2015NPL278960.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Neeraj Gupta and Ritu Gupta.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 234 Somdutt Chamber – II 9 Bhikaji Cama Place, New Delhi, Delhi, India – 110066.

As per the financials filed for FY 2025, the company reported a revenue of ₹26.15 Lakh, a growth of 56% compared to the previous year. For the same year it recorded a net profit of ₹16.01 Lakh (net margin 61.2%) and EBITDA of ₹16.01 Lakh (EBITDA margin 61.2%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 9% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U85100DL2015NPL278960
Registration Number 278960
Incorporation Date 13 April 2015
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Ils Foundation's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Flat No. 234 Somdutt Chamber – II 9 Bhikaji Cama Place, New Delhi, Delhi, India – 110066
  • Industry
    Pharma, Pharma Contract R&D

To see the full contact details of Ils Foundation, buy the company report.

Comprehensive company report
Ils Foundation - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Ils Foundation

FY 2025 filings available

Ils Foundation reported revenue of ₹26.15 Lakh (up 56% YoY) for FY 2025.

Revenue · FY 2025
₹26.15 Lakh ▲ 56%
Net profit · FY 2025
₹16.01 Lakh margin 61.2%
EBITDA · FY 2025
₹16.01 Lakh margin 61.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 56%
3 years · compounded
▲ 16%
5 years · compounded
▲ 9%
EBITDA CAGR growth
1 year
▲ 531%
3 years · compounded
▲ 20%
5 years · compounded
▲ 304%

Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 56% growth in the latest year. EBITDA rose 531% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹16.01 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹16.01 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin61.2%
Net Profit Margin61.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Ils Foundation, buy the company report.

Board of directors of Ils Foundation

Ils Foundation has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Neeraj GuptaDirector13 Apr 201511 Years 7 MonthsCurrent
Ritu GuptaDirector05 Dec 20241 Years 11 MonthsCurrent

Peer comparison

Ils Foundation is compared with the 10 companies closest to it by revenue in the Pharma industry (Contract Research), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Syntegrity Labs Private Limited₹26.68 Lakh (FY 2021)43.0%Hosur, Tamil Nadu, India
A P S Medical and Research Centre Pvt Ltd₹26.6 Lakh (FY 2024)12.0%Delhi, India
Indya Clinical Research Private Limited₹26.49 Lakh (FY 2025)-75.0%Bangalore, Karnataka, India
Synthetic Research Pharma Laboratories Private Limited₹26.32 Lakh (FY 2025)148.0%Hyderabad, Telangana, India
Poullac Pharmaceuticals Private Limited₹26.25 Lakh (FY 2025)-77.0%Saharanpur, Uttar Pradesh, India
Ils Foundationthis company₹26.15 Lakh (FY 2025)₹16.01 Lakh61.2%56.0%New Delhi, Delhi, India
Natural Elements Foundation₹26.14 Lakh (FY 2025)27.0%Gurgaon, Haryana, India
Nucleon Research Private Limited₹26.1 Lakh (FY 2025)Mumbai, Maharashtra, India
Crmo Pharmatech Private Limited₹24.57 Lakh (FY 2025)-28.0%Gandhinagar, Gujarat, India
Huda Medi Research Private Limited₹24.43 Lakh (FY 2025)132.0%Pune, Maharashtra, India
Ileads Therapeuircs Private Limited₹24.42 Lakh (FY 2024)-2.0%Hyderabad, Telangana, India

To see the full peer comparison of Ils Foundation, buy the company report.

Auditor

Ils Foundation is audited by K S BAWA & ASSOCIATES for the financial year 2018.

Auditor firmFinancial yearFirm registration number
K S BAWA & ASSOCIATESFY 2018003979N

Shareholding

The shareholding of Ils Foundation is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2018FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Ils Foundation, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Ils Foundation; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Ils Foundation; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Ils Foundation has 3 board changes on record since 2015: 2 appointments and 1 cessation. The latest: Suresh Kumar Gupta ceased to be Director on 06 Dec 2024.

AGM
Ils Foundation last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Ils Foundation has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Ceased
Suresh Kumar Gupta ceased to be Director.
Appointed
Ritu Gupta was appointed as Director.
Appointed
Neeraj Gupta was appointed as Director.
Incorporation
13 Apr 2015
Ils Foundation was registered on 13 Apr 2015 with Roc Delhi I & aged 11 years 7 months as per MCA records.

Frequently asked questions

Ils Foundation is an active private not for profit company based in New Delhi, Delhi, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 13 April 2015 (11+ years old) and is registered under CIN U85100DL2015NPL278960.

Ils Foundation has 2 current directors:

The latest financial statements of Ils Foundation on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.

The CIN (Corporate Identification Number) of Ils Foundation is U85100DL2015NPL278960. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Ils Foundation was incorporated on 13 April 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Ils Foundation by revenue are Syntegrity Labs Private Limited, A P S Medical and Research Centre Pvt Ltd, Indya Clinical Research Private Limited, Synthetic Research Pharma Laboratories Private Limited, Poullac Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Contract Research).

Suresh Kumar Gupta ceased to be Director on 06 Dec 2024. Ritu Gupta was appointed as Director on 05 Dec 2024. Neeraj Gupta was appointed as Director on 13 Apr 2015.

The registered office of Ils Foundation is at Flat No. 234 Somdutt Chamber – II 9 Bhikaji Cama Place, New Delhi, Delhi, India – 110066.

Ils Foundation operates in the pharma industry, in the pharma contract r and d segment.

The compliance status of Ils Foundation is compliant as of 06 August 2026. The company is actively filing with the Registrar of Companies.

Ils Foundation can be reached at its registered office: Flat No. 234 Somdutt Chamber – II 9 Bhikaji Cama Place, New Delhi, Delhi, India – 110066.